ACM Central Laboratory Expands its Business Development Team
ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%.
Rochester, New York -- April 4, 2005 -- ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%. Overwhelming demand for ACM Central Laboratory Services by new and existing customers has led to this growth.
ACM Central Laboratory Services has added U.S. business development directors in the Northeast, Southeast and on the West Coast. Tim Robey, Scott Keddy, Tab Moore and James Naumann join ACM's team of talented professionals. Highly experienced, these directors bring extensive knowledge of the clinical development industry. Their experience includes operational, clinical and business development responsibilities within contract research organizations (CRO), central labs, and pharmaceutical and biotech companies. In addition to sales in their respective regions, the directors will be responsible for ongoing client communication and ensuring customer satisfaction.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025